In this week's episode, Shashank and Mark dive deep into Nvidia's current dominance in the AI hardware space and the potential challengers on the horizon. As companies like AMD, Cerebras, and SambaNova work to chip away at Nvidia’s massive lead, is it time to reconsider your portfolio? Plus, we explore cutting-edge applications of generative AI in DNA analysis, gene therapy, and how AI agents could revolutionize everything from medical treatments to productivity tools.